The New York Office of Cannabis Management (OCM) has commenced accepting applications from licensed dispensaries seeking to host temporary Cannabis Showcase Events, including farmers’ markets and pop-up retail operations. This initiative aims to expand regulated market access for cultivators, processors, and retailers within the state’s established framework.

According to a report by Marijuana Moment, the OCM launched the application process for these events, which are designed to facilitate direct engagement between licensed businesses and consumers. John Kagia, OCM’s acting executive director, stated that these events expand opportunities within New York’s regulated market while maintaining strict safety standards, age restrictions, and local oversight. The objective is to provide flexibility for businesses while preserving public health safeguards and local authority.

Regulatory Framework for Cannabis Showcase Events

The introduction of these Cannabis Showcase Events follows legislation signed by Governor Kathy Hochul last year, which expanded upon an existing showcase program initially established in 2023. The state’s Cannabis Control Board (CCB) adopted the specific regulations for this program in May. CCB Chairperson Jessica Garcia noted the Board’s responsibility to ensure new business opportunities are implemented with clarity and consistency, allowing licensees to leverage seasonal opportunities while upholding public health standards.

Operational Guidelines and Restrictions

The OCM has outlined specific rules governing the operation of these temporary events:

  • Participation is restricted to individuals aged 21 and over.
  • Events require written approval from local officials.
  • Organisers must submit an advanced application to the OCM.
  • Compliance with distance requirements from schools, places of worship, and designated public youth facilities is mandatory.
  • Event organisers must submit detailed safety, security, and incident reporting plans.
  • On-site cannabis consumption is prohibited.
  • The provision of free samples or giveaways of cannabis products is not permitted.
  • Sales can only be conducted by the licensed retailer holding the event permit.
  • Cultivators and processors may showcase products but are not permitted to sell directly to attendees or provide samples.
  • Each event can operate for a maximum of 14 consecutive days.
  • A single venue is limited to hosting events for no more than 45 days within a calendar year.

Broader Market Context and Legislative Developments

These new regulations for Cannabis Showcase Events are part of New York’s ongoing efforts to refine and expand its regulated cannabis market. In March, Governor Hochul marked the five-year anniversary of adult-use marijuana legalization in New York, highlighting approximately US$3.3 billion in retail sales and the establishment of over 600 licensed cannabis shops. This market expansion is also aimed at promoting social equity and mitigating the illicit market.

Earlier in January, New York officials released reports detailing the evolution of the state’s medical and adult-use marijuana markets, noting record sales and revenue contributions to state coffers. The OCM annual report also indicated that Governor Hochul signed legislation to expand the state’s medical cannabis program, enhancing patient access and updating the program framework. Recent legislative activities include approvals for reciprocity for out-of-state medical marijuana patients and the availability of pre-rolled joints in the medical cannabis market. Additionally, legislation has been introduced to allow liquor and wine stores to sell low-dose cannabis-infused beverages, and zoning requirements for licensed marijuana businesses have been revised to offer greater flexibility for retailers near schools and places of worship.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.

Source link